8-K: Trulieve Secures Additional $60M in Senior Secured Notes

Trulieve Cannabis Corp. has closed a private placement of an additional US$60 million in 10.5% senior secured notes due 2030, bringing the total outstanding to US$200 million.

Summary

• Trulieve Cannabis Corp. issued an additional US$60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the "Additional Notes").
• The Additional Notes were issued at a price of US$1,000 plus accrued but unpaid interest of US$12.37 per US$1,000 principal from December 17, 2025, to January 29, 2026.
• The total outstanding aggregate principal amount of these notes, including the US$140 million Original Notes issued on December 17, 2025, is now US$200 million.
• The Notes bear interest at a rate of 10.5% per annum, payable semi-annually in arrears on June 17 and December 17 of each year, with interest accruing from December 17, 2025, and the first payment for Additional Notes due June 17, 2026.
• The Notes will mature on December 17, 2030, unless earlier redeemed or repurchased.
• Obligations under the Indenture and Notes are irrevocably and unconditionally guaranteed, jointly and severally, by the Company's Restricted Subsidiaries, with Trulieve, Inc. (Trulieve US) currently being the only one.
• The Notes are direct senior secured obligations of the Company, ranking senior to all existing and future unsecured indebtedness and secured solely by a pledge of the shares of Trulieve US.
• The Company intends to use the net proceeds from the offering for capital expenditures and other general corporate purposes.
• The offering was conducted on a best-efforts basis with Canaccord Genuity Corp. as the sole agent and bookrunner.
• The Company plans to make required filings to list the Notes on the Canadian Securities Exchange (CSE) following the expiry of the four-month Canadian statutory hold period.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as Trulieve successfully secured additional capital for its operations and growth, albeit at a relatively high cost of debt, which is typical for the cannabis industry.

Positives

• Successfully raised an additional US$60 million in capital, demonstrating continued access to financing for operations and growth.
• The capital raised will be deployed for capital expenditures and general corporate purposes, supporting the company's strategic initiatives and operational needs.

Negatives

• The issuance of additional debt increases the company's overall leverage and future interest payment obligations.
• The 10.5% interest rate represents a relatively high cost of capital, reflecting the perceived risk and financing environment for the cannabis industry.

Risks

• The filing references general risks discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and in its periodic reports subsequently filed with the United States Securities and Exchange Commission and on SEDAR+.

Future Outlook

The Company intends to use the net proceeds from the offering for capital expenditures and other general corporate purposes. It also plans to make required filings to list the Notes on the Canadian Securities Exchange (CSE) following the expiry of the four-month Canadian statutory hold period.

Industry Context

StockSavvy.ai notes that U.S. cannabis companies, such as Trulieve, frequently resort to private placements of high-yield debt due to federal prohibition, which restricts access to traditional banking and capital markets. The 10.5% interest rate on these senior secured notes is indicative of the higher cost of capital and elevated risk perception prevalent within the cannabis sector, reflecting the unique regulatory challenges faced by multi-state operators.

Comparison to Industry Standards

• The 10.5% interest rate on Trulieve's senior secured notes is significantly higher than what companies in federally legal and more established industries would typically pay for similar secured debt, which often ranges from 4-7% for investment-grade entities.
• Within the U.S. cannabis industry, however, such rates are common. For example, comparable multi-state operators like Green Thumb Industries (GTI) and Curaleaf have also issued secured notes in private placements with interest rates often in the high single-digit to low double-digit range, reflecting the sector's unique financing landscape.

Stakeholder Impact

• Shareholders: The capital raise provides funding for growth and operations, which could positively impact long-term shareholder value, but also introduces increased interest expense that could affect future profitability.
• Creditors: The new notes are direct senior secured obligations, providing noteholders with a relatively strong position in the capital structure, secured by a pledge of Trulieve US shares.

Next Steps

• The Company will make required filings to list the Notes on the Canadian Securities Exchange (CSE) following the expiry of the four-month Canadian statutory hold period.
• Semi-annual interest payments on the Notes will commence on June 17, 2026.

Key Dates

Recommendation

While the successful capital raise provides necessary funding for Trulieve's operations and growth, the high cost of debt (10.5%) and increased leverage warrant a cautious "hold" recommendation. The ability to secure funding is positive in the challenging cannabis financing environment, but the terms reflect inherent industry risks. Investors should monitor how the capital is deployed and its impact on future profitability and cash flow before considering a stronger position.

Keywords

Trulieve, TCNNF, TRUL, Cannabis, Senior Secured Notes, Debt Offering, Private Placement, Capital Raise, Corporate Finance, SEC Filing, 8-K, Fixed Income, Bond, Capital Expenditures, General Corporate Purposes